ImproveWell CEO named a rising star amongst top 50 female leaders in UK healthcare

2 November 2017, London (UK): ImproveWell LTD announces that its CEO and Co-founder, Lara Mott, has been named a “Rising Star” in a new report released today unveiling the top 50 female leaders in healthcare business in the UK.

Lara co-founded ImproveWell in 2016 to offer better ways for healthcare professionals to communicate quality improvement ideas to management. ImproveWell’s platform aggregates data, completes feedback loops and facilitates shared knowledge. The technology is already being used in multiple NHS Trusts across the UK. Previously, Lara spent 11 years in senior roles across healthcare specialist investment, biopharmaceutical, life sciences consulting and financial services businesses. She supported the £200 million Circassia Initial Public Offering and helped raise a €660 million healthcare private equity fund for GHO Capital. Lara holds a first class degree in Pharmacology from Bristol University where she was awarded the Hans Heller Memorial Prize for outstanding performance.

Produced by BioBeat, the report on 50 Movers and Shakers in BioBusiness 2017 emphasises how diversity of thinking is critical to the success of the sector in the UK. The report also celebrates how women are driving innovation in healthcare. It comes within weeks of the Government announcing that, by 2023, the UK should be in the top quartile of comparator countries for the speed of adoption and the overall uptake of innovative medicines, devices and digital products.

Lara Mott, CEO and Co-founder of ImproveWell, commented: “It is an honour to be named in this report together with so many talented women in healthcare. I am passionate about our industry and am privileged to have the opportunity to work with fantastic colleagues and peers to help improve the way we deliver healthcare.”

BioBeat Founder Miranda Weston-Smith said: “Women are transforming the pace, scale and ambition of what we can do in responding to global health challenges. I am so excited to present 50 Movers and Shakers in BioBusiness 2017 – they are outstanding innovators and leaders who are giving us all a healthier world.”

Nikki Yates, Senior Vice President, UK & Ireland Pharmaceuticals, GSK, said: “Diversity of talent is critical to life sciences and it is great to see the contribution these women are making. 50 Movers and Shakers in BioBusiness 2017 celebrates leaders whose dedication is about innovation in the healthcare business. It is fantastic to see that these are female leaders, and that they are recognised for the progress they have made over the past year.”